Summary
- The problem
- A count of 1 CFU means little without its location, grade, activity, exposure, incubation history, organism and batch window. Generic result tables force microbiologists to match plates back to rooms and batches after reading.
- Seal’s approach
- Samples are created from governed monitoring plans and manufacturing events, so the source context exists before the plate reaches the laboratory. Plan, sample, test, plate observation, result and quality decision stay distinct records, connected from plan to decision.
- What changes
- A missed sample cannot appear as a zero result, a corrected count keeps the original observation, and an excursion finds the products, people and equipment exposed in the same interval.
- Where to start
- One manufacturing exposure window, from scheduled monitoring through organism identification to batch disposition, including a missed location and an incubator excursion. Book a demo.
1A count means little without its source.
A count of 1 CFU changes meaning with the location and grade, the sample type, the activity under way, the exposure time or volume, the incubation history, the organism and the batch being filled at the time. A generic result table records the number and leaves the microbiologist to match plates back to rooms and batches after reading.
Seal creates samples from governed monitoring plans and manufacturing events, so that context exists before the plate reaches the laboratory. Environmental monitoring, utilities, sterility, bioburden, endotoxin, growth promotion and organism identification then stay connected to the place, activity, batch and decision they concern.
1.1Why teams choose Seal for microbiology
A microbiology module beside manufacturing can hold results, but the fill, the intervention and the batch window usually have to be added from other systems or entered by hand, days after the plate was exposed. Seal gives the laboratory and the operation shared records and a shared clock, so a sample exists with its context before it reaches the incubator. When a monitoring plan, alert level or incubation step changes, the change is versioned and approved with its own evidence, and earlier results stay tied to the plan they were collected under.
| Microbiology beside the operation | Seal | |
|---|---|---|
| Sample context | Added after reading, from logbooks and schedules | Created with the sample from the plan or manufacturing event |
| Missed or invalid work | Easy to mistake for a zero count or no growth | A distinct state, with reason and approval |
| Corrections | A new number replaces the old one | The original plate observation is retained with the reason for change |
| Excursions | A manual search for what was exposed | Products, people and equipment active in the same interval |
| Batch release | A summary of microbiology status | Required samples, incubations, organisms and investigations, with pending work shown as pending |
2Keep the plan, sample, observation, result and decision apart.
The plan says what should happen. The sample is what was physically collected. A test applies a method to that sample; plates and containers carry observations through time; the reportable result applies calculations and rules; a quality decision determines operational or product impact. Seal links these layers into one workflow without merging their meanings, which prevents the common ambiguities:
- a missed sample cannot appear as a zero result, and an unexposed plate cannot appear as no growth;
- a failed control cannot disappear behind a final numeric field;
- a corrected count does not replace the original plate observation;
- an isolate can continue through identification while its source result is already under review; and
- a batch decision can remain pending after analytical approval while impact assessment is open.
3Plan, collect and manufacture on one clock.
A monitoring plan defines the room, grade, location, sample type, method, frequency or event trigger, media, incubation, limits and required response.¹ A filling campaign, intervention, maintenance return or adverse trend can add work without changing the approved routine plan. Missed, inaccessible and replaced locations keep their reason and approval.
At collection, scanning confirms the room, location, sample identity and media, and the record keeps what matters for the method: sampled volume for active air, exposure start and end for settle plates, and the exact site and timing relative to activity for surfaces and personnel.
Room state, operations, batches, interventions, cleaning, alarms and samples share facility identity and time. An excursion can therefore find the products, people and equipment exposed in the relevant interval, and batch review can show the monitoring evidence for its own window. Annex 1 asks for monitoring to be assessed within a facility-wide contamination control strategy;² Seal keeps the relationships that assessment needs, while the manufacturer’s approved strategy remains in control.
Room B-02, filling suite
12 CFU/m³
Action limit 10
Investigation INV-2026-089
- Batches
- BATCH-2841, BATCH-2842
- Personnel
- 3 operators
- HVAC
- Normal, 30 Pa
- Adjacent rooms
- Below limits
- Organism ID
- Awaiting the lab
4Control media, incubation and reading as executed steps.
Prepared and purchased media carry their lot, preparation, sterilisation, expiry, growth-promotion requirement and release status. Configured checks can stop an unreleased or expired lot being issued to routine testing, and a later growth-promotion failure traces forward to every sample and decision that used the lot.
Incubation follows the method’s sequence, temperature ranges, durations and reading windows on an eligible incubator. Start, transfer, interruption, excursion and read events keep their actual times. A missed reading window is recorded as such, not converted into an ordinary completed incubation.
The reader records the count, morphology, uncountable or confluent growth, absence of growth and photographs where required. Corrections keep the original observation and the reason.³ Calculations apply the approved volume, area, dilution and reporting rules, and the reported result stays linked to every plate behind it.
5Give each test its own logic.
Microbiology tests do not share one result form. Sterility testing connects the product sample, method, containers, media, transfers, incubation, controls and environment, and distinguishes an invalid test from product impact or an inconclusive state according to the approved procedure. Bioburden and microbial limits keep each plate traceable to the reported population result. Endotoxin runs arrive with their standard curve, controls, dilution and interference checks.
An isolate keeps its source sample, subculture history, identification method, confidence and taxonomy version. Organism libraries give consistent naming without erasing the originally reported identity, and objectionable or recurring organisms can drive investigation and trending.
Identification systems, endotoxin readers, rapid methods, particle counters and incubator monitoring can integrate without Seal becoming the acquisition controller. Each interface defines its identifiers, timestamps, units, acknowledgement, retry and correction behaviour. Where manual transcription is still required, it receives verification proportionate to risk.
6Trend comparable populations, with the gaps shown.
The effective plan and specification set the initial status. Alert and action results, OOS product tests, objectionable organisms, invalid tests and data-quality failures stay distinct rather than collapsing into one red flag. The event opens with the sample, location, activity, batch, media, incubation, organism and neighbouring history attached, so containment can begin while the approved investigation proceeds.
Trends group by room, grade, location, sample type, method, organism, activity and plan version. Changes in limits, methods, taxonomy or sampling frequency create explicit boundaries, so incompatible periods are not mixed. The denominator shows expected and completed collections, invalid plates and results still in progress: a falling recovery rate is not an improvement if sampling or incubation completion fell with it. The microbiologist reviews each signal in its operational context before opening an investigation or changing limits, frequencies, disinfectants or the contamination control strategy.
7Release sees the complete microbiology state.
The disposition view shows required samples, collection completeness, incubation status, approved results, organism work, environmental context and open investigations. Pending remains pending.
Where the product and approved procedure permit release before a long-duration test completes, the release record keeps the evidence available at the time, the authorised basis and the required follow-up. A later adverse result attaches to that historical disposition and can prompt the responsible team’s assessment of notification or field action.
Start with one manufacturing exposure window: scheduled monitoring, personnel monitoring, media release, collection, incubation, reading, identification, investigation and batch disposition. Include a missed location, an incubator excursion, a corrected count and a failed instrument transfer. The workflow is ready when each event identifies the right physical population and shows the true state of its evidence.
References
- 1EudraLex Volume 4, Annex 1, Manufacture of Sterile Medicinal Products (2022), section 9 (environmental and process monitoring). European Commission
- 2EudraLex Volume 4, Annex 1, Manufacture of Sterile Medicinal Products (2022), section 2.3: a contamination control strategy should be implemented across the facility to define all critical control points and assess the effectiveness of all controls and monitoring measures. European Commission
- 3EudraLex Volume 4, Part I, Chapter 4, Documentation (2011), sections 4.8 to 4.10: records should be made at the time each action is taken, alterations should be signed and dated and permit reading of the original information, and secure controls must ensure record integrity throughout the retention period. European Commission
ACapabilities
| Capability | What it covers |
|---|---|
| Environmental monitoring | Risk-based plans, facility points, schedules, collection, incubation, limits, organisms, excursions and trends. |
| Sterility testing | Product samples, containers, media, methods, incubation, observations, controls, investigation and final conclusions. |
| Bioburden and microbial limits | Preparations, dilutions, filters, plates, replicates, recoveries, calculations, suitability, specifications and review. |
| Endotoxin testing | Samples, dilutions, readers, curves, controls, interference, calculations, limits, instrument data and approvals. |
| Media and reagent control | Receipt, preparation, sterilisation, release, growth promotion, storage, expiry, issue and use genealogy. |
| Incubation management | Incubators, positions, phases, temperatures, transfers, windows, excursions, reads and complete sample populations. |
| Organism management | Isolates, subcultures, identification, taxonomy, confidence, objectionable status, storage and related history. |
| Instrument integration | Readers, identifiers, rapid methods, counters, samplers and incubators exchange contextual evidence with recovery. |
| Excursion and OOS | Events begin with location, activity, batch, sample, media, incubation, observation, organism, method and history attached. |
| Batch impact and release | Collection, incubation, results, organism work, environmental state, investigations, conditions and later evidence reach disposition. |
BConnected records
CQuestions and answers
What is a pharmaceutical microbiology LIMS?
It manages microbiology-
How is microbiology LIMS different from a general LIMS?
Microbiology adds physical plates and containers, media genealogy, incubation phases and transfers, observation history, colony counts, isolates and taxonomy, growth-promotion evidence, environmental locations, exposure windows and organism-aware trending.
Can Seal manage environmental monitoring?
Yes. Seal can define risk-based plans and locations, schedule and collect viable and non-viable work, manage media and incubation, capture readings and organisms, apply limits, investigate excursions, trend results and connect the evidence to exposed batches.
How are samples connected to manufacturing batches?
Samples share facility location and time with manufacturing execution. The system relates collection and monitoring intervals to active operations, batches, interventions, people, cleaning and alarms, producing a bounded exposure population.
Can Seal manage sterility tests?
Yes. Configure the applicable method, containers, media, controls, transfers, incubation, observations, interventions, growth examination, investigation and conclusion. Exact procedures and scientific decisions remain governed by the laboratory.
How are microbial isolates tracked?
Each isolate retains source sample and plate, colony selection, morphology, subculture lineage, identification method, instrument or laboratory, taxonomy version, confidence, result, storage and disposition.
Does Seal support endotoxin and bioburden testing?
Yes. Test-specific workflows can capture preparations, dilutions, replicates, suitability or interference, instruments, raw data, calculations, specifications, review and true invalid or OOS states.
Can incubator data be integrated?
Yes. A monitoring system can remain authoritative for continuous data while Seal manages sample placement, phases, transfers, required ranges, actual intervals, excursions, source references and review.
How are alert and action levels handled?
The effective plan determines initial status and response. Alert, action, OOS, atypical organism, invalid test, excursion and adverse trend remain distinct states with the correct investigation and product-impact path.
Can the system trend organisms as well as counts?
Yes. Trends can compare count, recovery frequency, genus or species, flora grouping, objectionable status, room, location, activity, shift, operator, method, season and plan version without mixing incompatible populations.
How does microbiology affect batch release?
Release sees required collection, incubation, approved results, organisms, environmental context, investigations and later obligations. If an authorised release model allows pending long-duration evidence, its conditions and follow-up remain explicit.
What should the first microbiology LIMS implementation prove?
Follow one manufacturing exposure through planned monitoring, collection, media, incubation, reading, organism identification, excursion, trend and disposition. Include missed work, an incubation issue, a corrected count, integration failure and later adverse evidence.
